Claims
- 1. A method for treating glaucomatous optic neuropathy, said method comprising administering to a patient in need thereof a composition comprising a pharmaceutically effective amount of a peptide or protein comprising a sequence consisting of at least 8 contiguous amino acids from SEQ ID NO:2.
- 2. The method of claim 1, wherein the peptide comprises SEQ ID NO:4.
- 3. The method of claim 1, wherein the composition comprises a peptide comprising a sequence consisting of at least 9 contiguous amino acids from SEQ ID NO:2.
- 4. The method of claim 3, wherein the peptide comprises SEQ ID NO:8.
- 5. A method for treating glaucomatous optic neuropathy, said method comprising administering to a patient in need thereof a composition comprising a pharmaceutically effective amount of a peptide or protein comprising a sequence consisting of a sequence selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:6, and SEQ ID NO:7.
Parent Case Info
[0001] This application is a continuation-in-part of U.S. Ser. No. 09/921,029, filed Aug. 2, 2001, which claims priority from U.S. Provisional Application Serial No. 60/230,964 filed Sep. 7, 2000.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60230964 |
Sep 2000 |
US |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
09921029 |
Aug 2001 |
US |
Child |
10164432 |
Jun 2002 |
US |